Publications by authors named "Timothy A Lin"

Claim this Profile
B
Bayesian interim analysis and efficiency of phase III randomized trials.
Alexander D Sherry, Pavlos Msaouel, Avital M Miller, Timothy A Lin, Gabrielle S Kupferman, Christine Lin

Br J Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reproducibility of statistically significant phase III oncology trials: An In Silico meta-epidemiological analysis.
Alexander D Sherry, Pavlos Msaouel, Avital M Miller, Timothy A Lin, Joseph Abi Jaoude

Eur J Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient, Physician, and Assessor Blinding in Phase III Randomized Trials in Oncology: A Meta-Epidemiological Analysis.
Gabrielle Brown, Pavlos Msaouel, Avital M Miller, Ramez Kouzy, Timothy A Lin

Cancer Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incomplete Toxicity Reporting and Use of Toxicity-Minimizing Language in Phase III Oncology Trials.
Avital M Miller, Adina H Passy, Alexander D Sherry, Ramez Kouzy, Joseph Abi Jaoude, Timothy A Lin

JCO Oncol Pract· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall Survival and Quality-of-Life Superiority in Modern Phase 3 Oncology Trials: A Meta-Epidemiological Analysis.
Alexander D Sherry, Avital M Miller, Jnana Preeti Parlapalli, Gabrielle S Kupferman, Esther J Beck, Timothy A Lin

JAMA Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival-inferred fragility of statistical significance in phase III oncology trials.
Alexander D Sherry, Yufei Liu, Pavlos Msaouel, Timothy A Lin, Alex Koong, Christine Lin

NPJ Precis Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Justification, margin values, and analysis populations for oncologic noninferiority and equivalence trials: a meta-epidemiological study.
Troy J Kleber, Alexander D Sherry, Andrew J Arifin, Gabrielle S Kupferman, Ramez Kouzy, Timothy A Lin

J Natl Cancer Inst· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment group-specific inferences in Phase III Randomized Oncology Trials.
Alexander D Sherry, Adina H Passy, Joseph Abi Jaoude, Timothy A Lin, Ramez Kouzy

Acta Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival-Inferred Fragility of Statistical Significance in Phase III Oncology Trials.
Alexander D Sherry, Yufei Liu, Pavlos Msaouel, Timothy A Lin, Alex Koong, Christine Lin

medRxiv· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving the clinical meaning of surrogate endpoints: An empirical assessment of clinical progression in phase III oncology trials.
Alexander D Sherry, Timothy A Lin, Zachary R McCaw, Esther J Beck, Ramez Kouzy

Int J Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Off-Protocol Radiation Therapy in Phase 3 Metastatic Solid Tumor Trials.
Alexander D Sherry, Timothy A Lin, Zachary R McCaw, Esther J Beck, Ramez Kouzy

Int J Radiat Oncol Biol Phys· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proportional Hazards Violations in Phase III Cancer Clinical Trials: A Potential Source of Trial Misinterpretation.
Timothy A Lin, Zachary R McCaw, Alex Koong, Christine Lin, Joseph Abi Jaoude, Ruitao Lin

Clin Cancer Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidenced-Based Prior for Estimating the Treatment Effect of Phase III Randomized Trials in Oncology.
Alexander D Sherry, Pavlos Msaouel, Gabrielle S Kupferman, Timothy A Lin, Joseph Abi Jaoude

JCO Precis Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increasing Power in Phase III Oncology Trials With Multivariable Regression: An Empirical Assessment of 535 Primary End Point Analyses.
Alexander D Sherry, Adina H Passy, Zachary R McCaw, Joseph Abi Jaoude, Timothy A Lin

JCO Clin Cancer Inform· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials.
Esther J Beck, Alexander D Sherry, Marcus A Florez, Ramez Kouzy, Joseph Abi Jaoude, Timothy A Lin

Cancer Res Commun· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lost in the plot: missing visual elements in Kaplan-Meier plots of phase III oncology trials.
Alexander D Sherry, Pavlos Msaouel, Ramez Kouzy, Joseph Abi Jaoude, Timothy A Lin

Oncologist· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards Treatment Effect Interpretability: A Bayesian Re-analysis of 194,129 Patient Outcomes Across 230 Oncology Trials.
Alexander D Sherry, Pavlos Msaouel, Gabrielle S Kupferman, Timothy A Lin, Joseph Abi Jaoude, Christine Lin

medRxiv· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of differential censoring with survival and suboptimal control arms among oncology clinical trials.
Eric J Hsu, Timothy A Lin, Dor R Dabush, Zachary McCaw, Alex Koong, Christine Lin

J Natl Cancer Inst· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bayesian Interim Analysis and Efficiency of Phase III Randomized Trials.
Alexander D Sherry, Pavlos Msaouel, Avital M Miller, Timothy A Lin, Gabrielle S Kupferman, Christine Lin

medRxiv· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European association of urology biochemical recurrence risk stratification in the context of post-prostatectomy salvage therapy.
Timothy A Lin, Daniel Y Song

Transl Androl Urol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postprogression therapy and confounding for the estimated treatment effect on overall survival in phase III oncology trials.
Alexander D Sherry, Pavlos Msaouel, Timothy A Lin, Joseph Abi Jaoude, Ramez Kouzy

BMJ Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential Treatment Effects of Subgroup Analyses in Phase 3 Oncology Trials From 2004 to 2020.
Alexander D Sherry, Andrew W Hahn, Zachary R McCaw, Joseph Abi Jaoude, Ramez Kouzy, Timothy A Lin

JAMA Netw Open· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns and kinetics of hepatocellular carcinoma relapse post-liver transplantation: oligorecurrence and role of local therapies.
Timothy A Lin, Nicole Paul, Harry Luu, Diana Cheung, Behnam Saberi

J Gastrointest Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 Fallacy.
Alexander D Sherry, Pavlos Msaouel, Zachary R McCaw, Joseph Abi Jaoude, Eric J Hsu, Timothy A Lin

Eur J Cancer· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges, Complexities, and Considerations in the Design and Interpretation of Late-Phase Oncology Trials.
Timothy A Lin, Alexander D Sherry, Ethan B Ludmir

Semin Radiat Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis